Pulmonary fibrosis (PF) is a chronic pulmonary interstitial disease, and its pathological
process is closely related to fibroblast–myofibroblast differentiation. Danshensu (DSS) has …

Abstract Purpose/Aim: Pulmonary fibrosis (PF) is characterized by the progressive and
ultimately fatal accumulation of fibroblasts and extracellular matrix in the lung that distorts its …

Background Idiopathic pulmonary fibrosis (IPF) is a progressive and irreversible disease
characterized by excessive fibroblast to myofibroblast differentiation with limited therapeutic …

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterized by epithelial
cell damage, fibroblast activation, and collagen deposition. IPF has high mortality and …

Idiopathic pulmonary fibrosis (IPF) is one of the most common and devastating interstitial
lung diseases with poor prognosis. Currently, few effective drugs are available for IPF …

Aberrant activation of TGF-β1 is frequently encountered and promotes epithelial-
mesenchymal transition (EMT) and fibroblast activation in pulmonary fibrosis. The present …

Background: Pulmonary fibrosis (PF) is a terminal pathological change in a variety of lung
diseases characterized by excessive deposition of extracellular matrix, for which effective …

Background and objective Idiopathic pulmonary fibrosis (IPF) is a chronic fibrosing interstitial
lung disease with a poor prognosis. Indirubin, a compound obtained from indigo-bearing …

Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease (ILD). Pulmonary
fibroblasts play an important role in the development of IPF. Emerging evidence indicates …

Idiopathic pulmonary fibrosis is a progressive, irreversible lung disease that leads to
respiratory failure and death. Vincamine is an indole alkaloid obtained from the leaves of …